Copper and Cu NanoParticles / HO-1 Cancer Research Results

Cu, Copper and Cu NanoParticles: Click to Expand ⟱
Features:
Copper
Metal
Copper levels are considerably elevated in various malignancies.
Copper [Cu(II)] is a transition and trace element in living organisms. It increases reactive oxygen species (ROS) and free-radical generation that might damage biomolecules like DNA, proteins, and lipids.

Copper (dietary/physiology) ≠ copper-loading therapeutics ≠ copper nanoparticles.
For Cu nanoparticles, the dominant and most reproducible theme is toxicity via ROS → mitochondrial damage/genotoxicity, not clean tumor selectivity.
- Copper acts as a critical cofactor for numerous enzymes involved in redox reactions, energy production, and connective tissue formation.
- Increased copper levels in the tumor microenvironment can enhance angiogenic signaling and thus supply the tumor with necessary oxygen and nutrients, facilitating tumor growth and metastasis.
- Copper can participate in redox cycling reactions, similar to the Fenton reaction, leading to the production of reactive oxygen species (ROS).
- Cancer cells often exhibit altered copper homeostasis, with some studies showing elevated copper levels in tumor tissues relative to normal tissues.

Two main approaches are:
- Copper Chelation: Drugs that bind copper (chelators) can reduce the bioavailability of copper, potentially inhibiting angiogenesis and other copper-dependent tumor processes.
- Copper Ionophores: These agents facilitate the transport of copper into cancer cells to induce cytotoxicity by elevating intracellular copper levels beyond a tolerable threshold, leading to cell death.

- Depletion of glutathione and stimulation of lipid peroxidation, catalase and superoxide dismutase.
- Studies have shown that the level of copper in tumour cells and blood serum from cancer patients is elevated, and the conclusion is that cancer cells need more copper than healthy cells. (but also sometimes depleted).
- Copper is a double-edged sword, maintaining normal cell development and promoting tumor development.
- Tumor tissue has a higher demand for copper and is more susceptible to copper homeostasis, copper may modulate cancer cell survival through reactive oxygen species (ROS) excessive accumulation, proteasome inhibition and anti-angiogenesis.

Natural Product: Cu, Copper (ion biology)
Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Cuproptosis (copper-triggered mitochondrial cell death) Cu accumulation → binding to lipoylated TCA proteins → aggregation; Fe–S proteins ↓; proteotoxic stress ↑ Tight copper homeostasis usually prevents this R, G Regulated cell death (mitochondria-linked) Cuproptosis is a distinct copper-dependent death pathway tied to mitochondrial metabolism and lipoylated TCA components. :contentReference[oaicite:0]{index=0}
2 Copper homeostasis machinery (transport/chaperones) Copper trafficking affects tumor programs (growth/metastasis; context) Essential micronutrient; homeostasis prevents toxicity R, G Homeostasis / signaling coupling Copper import/export and chaperones couple copper availability to signaling and phenotype; dysregulation is increasingly discussed in cancer biology. :contentReference[oaicite:1]{index=1}
3 Angiogenesis support (copper-dependent tumor vascularization) Pro-angiogenic tone supported by copper availability (context) Physiologic angiogenesis/wound repair support G Vascular program modulation Copper deficiency/chelation has been reported to impair tumor angiogenesis in preclinical/clinical contexts. :contentReference[oaicite:2]{index=2}
4 LOX/LOXL family (ECM remodeling; copper-dependent enzymes) ECM crosslinking / invasion-metastasis programs ↑ (context) Normal ECM maturation and tissue repair G Microenvironment remodeling LOX enzymes are copper-dependent and implicated in tumor stroma remodeling and metastatic niche biology. :contentReference[oaicite:3]{index=3}
5 ROS / redox chemistry (Cu redox cycling) Oxidative stress ↑ (context); DNA/protein damage ↑ Redox enzyme cofactor; excess is toxic P, R, G Stress amplification (conditional) Copper can catalyze redox reactions; whether this is tumor-selective depends on copper handling, antioxidants, and exposure context.
6 Copper ionophores / copper-loading strategies (research/therapy concept) Intracellular Cu ↑ → stress/death programs ↑ (context) — R, G Therapeutic lever (conceptual) Reviews discuss copper ionophores as tools to drive copper accumulation and explore cuproptosis/ROS mechanisms; clinical positioning varies. :contentReference[oaicite:4]{index=4}
7 Copper chelation (anti-angiogenic / microenvironment strategy) Angiogenesis and tumor progression pressure ↓ (context) Risk of deficiency if excessive G Translation/strategy axis Tetrathiomolybdate and related chelation strategies have been studied clinically as anti-angiogenic approaches. :contentReference[oaicite:5]{index=5}

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid redox interactions)
  • R: 30 min–3 hr (acute mitochondrial/proteotoxic stress signaling)
  • G: >3 hr (gene-regulatory adaptation and phenotype outcomes)

Copper Nanoparticles: CuNP / CuO-NP (tox + “anticancer” claims are mostly preclinical)
Rank Axis Cell/Tumor Context Whole-Body / Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Oxidative stress (ROS generation) + antioxidant depletion ROS ↑; lipid peroxidation ↑; DNA damage ↑ (reported) Liver/kidney oxidative injury risk ↑ in animal studies P, R, G Primary toxicity driver CuO nanoparticles are widely reported to cause cytotoxicity primarily via oxidative stress leading to genotoxicity. :contentReference[oaicite:6]{index=6}
2 Mitochondrial dysfunction ΔΨm ↓; ATP ↓; apoptosis signaling ↑ (reported) Organ toxicity links include mitochondrial impairment R, G Energy failure / apoptosis coupling Mitochondria-mediated apoptosis has been reported with CuO NPs in cell models (e.g., HepG2). :contentReference[oaicite:7]{index=7}
3 Inflammation / immune activation Inflammatory signaling ↑ (context) Inflammation contributes to organ injury in vivo R, G Tissue injury amplification Sub-chronic exposure reviews describe inflammation as part of CuNP/CuO-NP toxicity patterns. :contentReference[oaicite:8]{index=8}
4 Genotoxicity DNA strand breaks ↑; chromosomal damage ↑ (reported) Potential long-term risk signal (model-dependent) R, G Genome damage Often downstream of ROS; repeatedly reported across CuO NP toxicity literature. :contentReference[oaicite:9]{index=9}
5 “Anticancer” cytotoxicity claims (preclinical) Viability ↓ in various cell lines (often at high concentrations) Translation limited by toxicity and exposure constraints G Non-selective cytotoxicity risk Many studies show tumor cell killing, but often at concentrations that also harm normal cells; selectivity is a major issue. :contentReference[oaicite:10]{index=10}
6 Reproductive/developmental toxicity signals (animal models) — Reported reproductive system impacts in animal studies G Safety constraint Recent studies discuss reproductive toxicity and mitochondrial injury in germline cells with CuO NPs. :contentReference[oaicite:11]{index=11}

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid ROS/redox interactions at particle surfaces)
  • R: 30 min–3 hr (mitochondrial stress + inflammatory signaling)
  • G: >3 hr (genotoxicity, apoptosis, organ-level outcomes)
HO-1, HMOX1: Click to Expand ⟱
Source:
Type:
(Also known as Hsp32 and HMOX1)
HO-1 is the common abbreviation for the protein (heme oxygenase‑1) produced by the HMOX1 gene.
HO-1 is an enzyme that plays a crucial role in various cellular processes, including the breakdown of heme, a toxic molecule. Research has shown that HO-1 is involved in the development and progression of cancer.
-widely regarded as having antioxidant and cytoprotective effects
-The overall activity of HO‑1 helps to reduce the pro‐oxidant load (by degrading free heme, a pro‑oxidant) and to generate molecules (like bilirubin) that can protect cells from oxidative damage

Studies have found that HO-1 is overexpressed in various types of cancer, including lung, breast, colon, and prostate cancer. The overexpression of HO-1 in cancer cells can contribute to their survival and proliferation by:
  Reducing oxidative stress and inflammation
  Promoting angiogenesis (the formation of new blood vessels)
  Inhibiting apoptosis (programmed cell death)
  Enhancing cell migration and invasion
When HO-1 is at a normal level, it mainly exerts an antioxidant effect, and when it is excessively elevated, it causes an accumulation of iron ions.

A proper cellular level of HMOX1 plays an antioxidative function to protect cells from ROS toxicity. However, its overexpression has pro-oxidant effects to induce ferroptosis of cells, which is dependent on intracellular iron accumulation and increased ROS content upon excessive activation of HMOX1.

-Curcumin   Activates the Nrf2 pathway leading to HO‑1 induction; known for its anti‑inflammatory and antioxidant effects.
-Resveratrol  Induces HO‑1 via activation of SIRT1/Nrf2 signaling; exhibits antioxidant and cardioprotective properties.
-Quercetin   Activates Nrf2 and related antioxidant pathways; contributes to anti‑oxidative and anti‑inflammatory responses.
-EGCG     Promotes HO‑1 expression through activation of the Nrf2/ARE pathway; also exhibits anti‑inflammatory and anticancer properties.
-Sulforaphane One of the most potent natural HO‑1 inducers; triggers Nrf2 nuclear translocation and upregulates a battery of phase II detoxifying enzymes.
-Luteolin    Induces HO‑1 via Nrf2 activation; may also exert anti‑inflammatory and neuroprotective effects in various cell models.
-Apigenin   Has been reported to induce HO‑1 expression partly via the MAPK and Nrf2 pathways; also known for anti‑inflammatory and anticancer activities.
Scientific Papers found: Click to Expand⟱
1571- Cu,    Copper in cancer: From pathogenesis to therapy
- Review, NA, NA
*toxicity↝, ROS↑, lipid-P↓, HNE↑, MAPK↑, JNK↑, AP-1↑, Beclin-1↑, ATG7↑, TumAuto↑, Apoptosis↑, HO-1↑, NQO1↑, mt-ROS↑, Fenton↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

Fenton↑, 1,   HNE↑, 1,   HO-1↑, 1,   lipid-P↓, 1,   NQO1↑, 1,   ROS↑, 1,   mt-ROS↑, 1,  

Core Metabolism/Glycolysis ⓘ

ATG7↑, 1,  

Cell Death ⓘ

Apoptosis↑, 1,   JNK↑, 1,   MAPK↑, 1,  

Autophagy & Lysosomes ⓘ

Beclin-1↑, 1,   TumAuto↑, 1,  

Migration ⓘ

AP-1↑, 1,  
Total Targets: 14

Pathway results for Effect on Normal Cells:


Functional Outcomes ⓘ

toxicity↝, 1,  
Total Targets: 1

Scientific Paper Hit Count for: HO-1, HMOX1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:64  Target#:597  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page